肽類治療藥物市場：依產品類型、應用、給藥途徑及地區分類

Peptide Therapeutics Market, By Product Type, By Application, By Route of Administration, and By Region

出版日期: 2025年10月29日 | 出版商:

Coherent Market Insights | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

肽類藥物市場預計在 2025 年達到 504.394 億美元，預計到 2032 年將達到 788.988 億美元，2025 年至 2032 年的複合年成長率為 6.6%。

報告內容		報告詳情
基準年：	2024	2025年市場規模：	504.394億美元
歷史數據時期：	2020年至2024年	預測期：	2025年至2032年
預測期（2025-2032年）複合年成長率：	6.60%	2032 年的預測值：	78,898,800,000 美元

由於新型生產、修飾和分析技術的進步，胜肽類藥物的研發取得了顯著進展。利用化學和生物方法進行胜肽的生成和修飾，以及建立克服胜肽特異性挑戰的新型設計和遞送策略，推動了該領域的持續發展。目前已有大量天然和修飾胜肽可用於治療多種疾病，包括心血管代謝疾病、免疫學、皮膚病學和腫瘤學，並正在進行相關研究。 21世紀的到來開啟了胜肽類藥物研發的新紀元，結構生物學、重組生物製藥以及新型合成和分析技術的進步顯著加速了這一進程。一個完善的胜肽類藥物研發系統已經建立，涵蓋胜肽類藥物發現、藥物設計、胜肽合成、結構修飾和活性評估等環節。

治療性胜肽是一類獨特的藥物，由規則的胺基酸序列組成，分子量通常在 500 至 5000 道爾頓 (Da) 之間。

市場動態

市場參與者正在開發創新胜肽類療法，透過增強生物相容性和顯著的治療效果，為目標患者提供客製化解決方案。預計癌症、心血管疾病和糖尿病的日益普及將推動胜肽類療法市場在預測期內的成長。

預計在預測期內，主要市場參與者擴大採用內部成長策略（例如透過合作拓展產品系列組合）將推動市場成長。例如，2023年1月，全球最大的製藥公司之一禮來公司和全球醫療保健公司默克公司宣佈在肽靶向藥物遞送技術領域建立合作夥伴關係，並透露雙方將合作收購生物製藥公司Peptidream。

本報告的主要特點

本報告對全球胜肽類藥物市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模和複合年成長率，以 2024 年為基準年。
它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
全球肽類藥物市場的主要企業將根據以下參數進行分析，例如公司概況、產品系列、主要亮點、財務績效和策略。
本報告提供的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作關係、市場擴張和行銷策略做出明智的決策。
《全球胜肽類藥物市場》報告涵蓋了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過各種用於分析全球胜肽類藥物市場的策略矩陣，更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 50,439.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.60%	2032 Value Projection:	USD 78,898.8 Mn

Peptide drug development has grown immensely due to new manufacturing, modification, and analytical techniques. Peptides are generated and modified using both chemical and biological methods, along with new design and delivery strategies that overcomes the inherent drawbacks of peptide and enables continued progress in this field. A wide variety of natural and modified peptides have been obtained and studied covering multiple therapeutic area such as cardio metabolic, immunology and dermatology, oncology, etc. Peptide drug development entered a new era with the advent of the 21st century, since then advances in structural biology, recombinant biologics, and new synthetic and analytic technologies have significantly accelerated the process. A sophisticated system of peptide drug development has been established, including peptide drug discovery, drug design, peptide synthesis, structural modification, and activity evaluation.

Therapeutic peptides are a unique class of pharmaceuticals composed of an ordered series of amino acids, typically with molecular weights between 500 and 5000 Da.

Market Dynamics

Market players are developing novel and innovative peptide therapeutics to provide tailored solutions for target patients, by enhancing biocompatibility and potent therapeutic efficacy. Increasing prevalence of cancer, cardiovascular diseases, and diabetes mellitus is projected to drive growth of the peptide therapeutics market over the forecast period.

Increasing adoption of organic growth strategies such as collaborations by key players in the market in order to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2023, Lilly, one of the world's largest pharmaceutical companies, and Merck, a global healthcare company, announced their partnership for peptide-targeted drug delivery, collaborating to acquire PeptiDream which is a biopharmaceutical company.

Key features of the study

This report provides in-depth analysis of the global peptide therapeutics market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global peptide therapeutics market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study Teva Pharmaceutical Industries Ltd, Novo Nordisk A/S, OPKO Health, Inc., Lilly, Hanmi Pharm.Co., Sanofi, Circle Pharma, Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global peptide therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide therapeutics market

Peptide Therapeutics Market Segmentation

Product Type Insights (Revenue, USD Mn, 2020 - 2032)
- Branded Peptide
- Generic Peptide
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Cancer
- Cardiovascular diseases
- Metabolic diseases
- Respiratory diseases
- Infectious diseases
- Others
Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
- Oral Administration
- Parenteral Administration
- Others
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Teva Pharmaceutical Industries Ltd
- Novo Nordisk A/S
- OPKO Health Inc.
- Lilly
- Hanmi Pharm.Co.
- Sanofi
- Circle Pharma
- Pfizer Inc.
- Novartis AG
- PeptiDream Inc.
- Amgen Inc.
- AstraZeneca
- Bachem Holding AG
- CordenPharma International
- Ipsen Pharma
- Merck KGaA
- PolyPeptide Group
- Bayer AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Route of Administration
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
PORTER's Analysis
Pricing Analysis (2021)

4. Global Peptide Therapeutics Market- Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Peptide Therapeutics Market, By Product Type, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Branded Peptide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Generic Peptide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

6. Global Peptide Therapeutics Market, By Application, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Cardiovascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Metabolic Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

7. Global Peptide Therapeutics Market, By Route of Administration, 2020-2032, (US$ Million)

Oral Administration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Parenteral Administration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

8. Global Peptide Therapeutics Market, By Region, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
OPKO Health, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lilly
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hanmi Pharm.Co.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Circle Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PeptiDream Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bachem Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CordenPharma International
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ipsen Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PolyPeptide Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies